Guzmán, M <br/><br/>
A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.  [electronic resource] 

 -  British journal of cancer  Jul 2006 
 - 197-203 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6603236  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biopsy<br/>Brain Neoplasms--drug therapy<br/>Cannabinoid Receptor Antagonists<br/>Cell Proliferation--drug effects<br/>Disease Progression<br/>Dronabinol--adverse effects<br/>Female<br/>Glioblastoma--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Pilot Projects<br/>Receptors, Cannabinoid--biosynthesis<br/>Safety<br/>Survival Rate<br/>Treatment Outcome<br/>Tumor Cells, Cultured